Skip to main content

and
  1. Article

    Open Access

    Vesical imaging reporting and data system (VI-RADS) could predict the survival of bladder-cancer patients who received radical cystectomy

    Vesical Imaging Reporting and Data System (VI-RADS) shows good potential in determining muscle-invasive bladder cancer (MIBC) patients. However, whether VI-RADS could predict the prognosis of radical cystectom...

    Juntao Zhuang, Lingkai Cai, Huanyou Sun, Qikai Wu, Kai Li, Ruixi Yu in Scientific Reports (2023)

  2. Article

    Open Access

    The application value of multi-parameter cystoscope in improving the accuracy of preoperative bladder cancer grading

    To develop and validate a preoperative cystoscopic-based predictive model for predicting postoperative high-grade bladder cancer (BCa), which could be used to guide the surgical selection and postoperative tre...

    Qikai Wu, Lingkai Cai, Baorui Yuan, Qiang Cao, Juntao Zhuang, Meiling Bao in BMC Urology (2022)

  3. Article

    Open Access

    External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center

    To investigate whether Pentafecta is suitable for bladder cancer patients receiving laparoscopic radical cystectomy (LRC).

    Kai Li, **ao Yang, Juntao Zhuang, Lingkai Cai, Jie Han, Hao Yu, Zijian Zhou in BMC Urology (2022)

  4. Article

    Open Access

    Three-dimensional corrective exercise therapy for idiopathic scoliosis: study protocol for a prospective non-randomized trial

    Although physiotherapeutic scoliosis-specific exercises (PSSEs) with or without other conservative treatments may improve scoliotic deformities, the evidence is insufficient. Three-dimensional corrective exerc...

    Xuan Zhou, **n Li, Qikai Wu, Ju** Liang, Haibin Guo in BMC Musculoskeletal Disorders (2022)

  5. No Access

    Article

    Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trial

    Traditional Chinese medicine (TCM) is widely accepted and prescribed in China alongside Nucleoside analogs (NAs). In this double-blind, placebo-controlled, randomized, multi-center trial, we evaluated whether ...

    **aoke Li, Daqiao Zhou, **aoling Chi, Qin Li, Li Wang in Hepatology International (2020)

  6. Article

    Open Access

    Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multi-center, double-blind, randomized controlled trial in China

    Nucleos(t)ide analogues (NAs) are the first-line option against chronic hepatitis B (CHB). NAs produce potent suppression of viral replication with a small chance of HBsAg seroclearance and a high risk of viro...

    **aoke Li, Ludan Zhang, Mei Qiu, Yi Huang, Huanming **ao, Bingjiu Lu in Trials (2020)

  7. Article

    Open Access

    Mechanism of RNA modification N6-methyladenosine in human cancer

    Since the breakthrough discoveries of DNA and histone modifications, the field of RNA modifications has gained increasing interest in the scientific community. The discovery of N6-methyladenosine (m6A), a pred...

    Zijian Zhou, Jiancheng Lv, Hao Yu, Jie Han, **ao Yang, Dexiang Feng in Molecular Cancer (2020)